MedMira Inc. (TSXV:MIR)
Canada · Delayed Price · Currency is CAD 0.0650
+0.0050 (8.33%)
Aug 10, 2026, 1:04 PM EST
MedMira Balance Sheet
Financials in millions CAD. Fiscal year is August - July.
Millions CAD. Fiscal year is Aug - Jul.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 30, 2026 | Jul '25 Jul 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 |
Cash & Equivalents | - | 0.01 | 2.1 | 0.01 | 0.03 | - |
Cash & Short-Term Investments | - | 0.01 | 2.1 | 0.01 | 0.03 | - |
Cash Growth | - | -99.29% | 15817.40% | -60.62% | -91.67% | - |
Accounts Receivable | 1.3 | 1.32 | 1.33 | 1.26 | 1.25 | 1.25 |
Inventory | 0.19 | 0.21 | 0.18 | 0.18 | 0.2 | 0.24 |
Other Current Assets | 0.05 | 0.06 | 0.07 | 0.24 | 0.17 | 0.09 |
Total Current Assets | 1.54 | 1.6 | 3.68 | 1.69 | 1.66 | 1.58 |
Net Property, Plant & Equipment | 1.86 | 2.08 | 2.39 | 1.96 | 2.17 | 2.31 |
Other Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 |
Total Assets | 3.4 | 3.68 | 6.07 | 3.65 | 3.83 | 3.89 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 30, 2026 | Jul '25 Jul 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 |
Accounts Payable | 3.29 | 2.91 | 2.72 | 3.26 | 2.75 | 2.7 |
Accrued Expenses | 6.48 | 5.84 | 5.1 | 4.54 | 3.97 | 4.05 |
Short-Term Debt | 0 | - | - | - | - | 0.01 |
Current Portion of Long-Term Debt | 7.12 | 6.3 | 6.11 | 6.14 | 6.1 | 9.18 |
Current Portion of Leases | 0.19 | 0.18 | 0.3 | 0.17 | 0.15 | 0.14 |
Unearned Revenue | 0.63 | 0.64 | 0.64 | 0.75 | 0.6 | 1.2 |
Other Current Liabilities | 7.69 | 6.14 | 6.09 | 0.86 | 0.57 | 0.13 |
Total Current Liabilities | 25.4 | 22.02 | 20.95 | 15.73 | 14.14 | 17.41 |
Long-Term Debt | 0.45 | 2.01 | 0.89 | 1.12 | 0.04 | 0.04 |
Long-Term Leases | 2.07 | 2.21 | 2.26 | 1.84 | 2.01 | 2.16 |
Total Long-Term Liabilities | 2.52 | 4.22 | 3.15 | 2.96 | 2.05 | 2.2 |
Total Liabilities | 27.92 | 26.24 | 24.11 | 18.68 | 16.19 | 19.61 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 30, 2026 | Jul '25 Jul 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 |
Common Stock | 68.67 | 68.67 | 68.67 | 68.35 | 68.35 | 63.9 |
Additional Paid-in Capital | 14.58 | 14.58 | 14.58 | 14.58 | 14.58 | 13.82 |
Retained Earnings | -107.76 | -105.81 | -101.29 | -97.96 | -95.28 | -93.45 |
Shareholders' Equity | -24.52 | -22.56 | -18.04 | -15.03 | -12.36 | -15.72 |
Total Liabilities & Equity | 3.4 | 3.68 | 6.07 | 3.65 | 3.83 | 3.89 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 30, 2026 | Jul '25 Jul 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 |
Total Debt | 9.83 | 10.71 | 9.56 | 9.27 | 8.3 | 11.54 |
Net Cash (Debt) | -9.83 | -10.69 | -7.46 | -9.26 | -8.27 | -11.54 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 |
Book Value | -24.52 | -22.56 | -18.04 | -15.03 | -12.36 | -15.72 |
Book Value Per Share | -0.03 | -0.03 | -0.03 | -0.02 | -0.02 | -0.02 |
Tangible Book Value | -24.52 | -22.56 | -18.04 | -15.03 | -12.36 | -15.72 |
Tangible Book Value Per Share | -0.03 | -0.03 | -0.03 | -0.02 | -0.02 | -0.02 |